Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval

Por: WPLG Local 10 Health September 15, 2023

thumbnail

The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also... + full article



Similar News

Success of MDMA in PTSD Study Could Pave the Way for U.S. Approval

Time USA Health September 16, 2023

thumbnailThe psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD... + más

New Study Supports MDMA As A Treatment For PTSD | Forbes

MDMA Therapy Inches Closer to Approval | The New York Times


Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval

ABC News USA Health September 15, 2023

thumbnailThe psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD... + más

New Study Supports MDMA As A Treatment For PTSD | Forbes

Psychedelic drug MDMA eases PTSD symptoms in a study that paves the way for possible US approval | WPLG Local 10


MDMA Therapy Inches Closer to Approval

The New York Times USA Health September 14, 2023

thumbnailMDMA-assisted therapy seems to be effective in , according to a study published on Thursday.The research is the final trial conducted by MAPS Public Benefit Corporation, a company that is developing prescription psychedelics. It plans to submit the results to the Food and Drug... + más

Australia will allow prescription MDMA and magic mushrooms for some people with mental illness | ABC News

New Study Supports MDMA As A Treatment For PTSD | Forbes


MDMA expected to be approved to treat PTSD by October: study

New York Post USA Life April 22, 2023

thumbnailThe US Food and Drug Administration will be asked to approve MDMA to treat post-traumatic stress disorder by October — opening the door to the use of hallucinogenic drugs to treat mental illness. If approved, the drug will be available in hospitals before the second half of... + más

Australia will allow prescription MDMA and magic mushrooms for some people with mental illness | ABC News

New Study Supports MDMA As A Treatment For PTSD | Forbes


What Are the Duties of A Trustee?

Forbes USA Business March 27, 2023

thumbnailLight Bulbs Concept Shining ETHICS, RESPECT, HONESTY and INTEGRITYgetty Previously, I wrote on in some detail, but did not go into the duties the Trustee of a Trust owes to the Trust’s beneficiary. To summarize, a Trust is an agreement written by the owner of the property,... + más

Selecting The Right Trustee To Manage Your Trust | Forbes

Author Post: Using Land Trusts For Anonymity And Asset Protection | Forbes


Australia will allow prescription MDMA and magic mushrooms for some people with mental illness

ABC News USA Health March 04, 2023

thumbnailAustralian regulators announced in February that psychiatrists will be able to for certain mental health conditions starting July 1 of this year. The move makes Australia the first nation to approve the legal use of MDMA and psilocybin.This is a major regulatory step forward as... + más

New Study Supports MDMA As A Treatment For PTSD | Forbes

Australia The First Nation To Approve The Legal Use Of MDMA And Psilocybin | Forbes


New Study Supports MDMA As A Treatment For PTSD

Forbes USA Life January 17, 2023

thumbnailA California biopharmaceutical company has announced positive results from a clinical trial testing MDMA as a treatment for post-traumatic stress disorder, bolstering its efforts to gain federal approval for the therapeutic use of the psychedelic drug also known as ecstasy. A... + más

Op-Ed: Psychedelic treatments are here, but doctors aren't prepared | Los Angeles Times

MDMA use at start of pandemic rose almost 300 percent in New England town | Newsweek



About iurex | Privacy Policy | Disclaimer |